间苯二胺

间苯二胺用途

【用途一】
用作分析试剂、树脂固化剂和阻聚剂，也用于染料的合成
【用途二】
主要用作染料中间体及环氧树脂固化剂
【用途三】
偶氮染料和吖嗪染料的中间体，主要用于制造直接耐晒黑RN、碱性橙、碱性棕G、直接耐晒黑G等染料，并用作毛皮染料，在日本，偶氮染料消费的间苯二胺占总消费量的90%。也用作环氧树脂的固化剂、水泥的促凝剂，并用于染发水、媒染剂、显色剂等方面。
【用途四】
分光光度测定亚硝酸盐，检定溴酸盐、溴化物、铬酸盐、臭氧、金、铜、重铬酸盐、铁、氧和铂，测定活性氯、铬、铱、亚硝酸盐和钯。

间苯二胺名称

[ CAS 号 ]:
108-45-2

[ 中文名 ]:
间苯二胺

[ 英文名 ]:
m-Phenylenediamine

[中文别名 ]:

[英文别名 ]:

m-Phenylenediamine
meta-Phenylenediamine (MPD)
3-Aminoaniline
m-aminoaniline
meta-Diaminobenzene
Phenylenediamine
Benzene-1,3-diamine
MFCD00007799
1,3-diaminobenzene
EINECS 203-584-7

间苯二胺物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
283.2±13.0 °C at 760 mmHg

[ 熔点 ]:
64-66 °C(lit.)

[ 分子式 ]:
C₆H₈N₂

[ 分子量 ]:
108.141

[ 闪点 ]:
147.6±19.3 °C

[ 精确质量 ]:
108.068748

[ PSA ]:
52.04000

[ LogP ]:
-0.31

[ 外观性状 ]:
灰色至白色晶体熔点

[ 蒸汽密度 ]:
3.7 (vs air)

[ 蒸汽压 ]:
0.0±0.6 mmHg at 25°C

[ 折射率 ]:
1.661

[ 储存条件 ]:
库房通风低温干燥,与食品原料分开储运

[ 水溶解性 ]:
350 g/L (25 ºC)

间苯二胺MSDS

详细MSDS(安全技术说明书)

间苯二胺毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: SS7700000

CHEMICAL NAME :: m-Phenylenediamine

CAS REGISTRY NUMBER :: 108-45-2

BEILSTEIN REFERENCE NO. :: 0471357

LAST UPDATED :: 199712

DATA ITEMS CITED :: 45

MOLECULAR FORMULA :: C6-H8-N2

MOLECULAR WEIGHT :: 108.16

WISWESSER LINE NOTATION :: ZR CZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 280 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 283 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 460 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Unreported

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 351 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 67700 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 400 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 90 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Unreported

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 65300 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 17 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Mammal - cat

DOSE/DURATION :: 300 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - cyanosis

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 437 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Administration onto the skin

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 5 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 200 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - cyanosis

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Unreported

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 438 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 450 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Unreported

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 450 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Bird - wild bird species

DOSE/DURATION :: 562 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1485 mg/kg/47W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 375 mg/kg

SEX/DURATION :: male 30 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - fetal death

TYPE OF TEST :: Micronucleus test

TYPE OF TEST :: DNA inhibition

MUTATION DATA

TYPE OF TEST :: Cytogenetic analysis

TEST SYSTEM :: Rodent - hamster Lung

DOSE/DURATION :: 12 mg/L

REFERENCE :: GMCRDC Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- Volume(issue)/page/year: 27,95,1981 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 0.1 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 16,111,1978 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 16,111,1978 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-SWITZERLAND:TWA 0.1 mg/m3;Skin JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 83124 No. of Facilities: 1364 (estimated) No. of Industries: 18 No. of Occupations: 21 No. of Employees: 12590 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 83124 No. of Facilities: 3739 (estimated) No. of Industries: 12 No. of Occupations: 18 No. of Employees: 40632 (estimated) No. of Female Employees: 32320 (estimated)

间苯二胺安全信息

[ 符号 ]:

GHS06, GHS08, GHS09

[ 信号词 ]:
Danger

[ 危害声明 ]:
H301 + H311 + H331-H317-H319-H341-H410

[ 警示性声明 ]:
P261-P273-P280-P301 + P310-P305 + P351 + P338-P311

[ 个人防护装备 ]:
Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
T:Toxic

[ 风险声明 (欧洲) ]:
R23/24/25;R36;R40;R43;R50/53

[ 安全声明 (欧洲) ]:
S28-S36/37-S45-S60-S61-S28A

[ 危险品运输编码 ]:
UN 1673 6.1/PG 3

[ WGK德国 ]:
2

[ RTECS号 ]:
SS7700000

[ 包装等级 ]:
III

[ 危险类别 ]:
6.1

[ 海关编码 ]:
29215119

间苯二胺合成路线

详细合成路线

间苯二胺上下游产品

间苯二胺上游产品

间苯二胺下游产品

间苯二胺制备

硝基苯经混酸硝化成间、邻、对二硝基苯的混合物，再经亚硫酸钠和液碱精制得间二硝基苯，然后用铁粉还原或加氢还原制得间苯二胺。工艺过程： 1.铁粉还原法首先向还原釜中加入一定量的上一批的洗浓液，开动搅拌器，加入铁粉和盐酸，升温活化；滴加间二硝基苯进行还原反应，温度控制在98-102℃；经保温合格后加纯碱中和至PH值为9，过滤是在翻斗过滤机中真空抽滤，滤液抽出后，需用热水洗涤6遍，前茅遍并入还原液贮槽，后3遍洗液供还原之用。然后将还原液经高位槽加入蒸发器，在真空度0.03MPa和65℃条件下进行蒸发。芤液经蒸馏釜先驱水后蒸料，蒸馏时真空度为0.09-0.05MPa原，温度170-180℃。真空蒸发和蒸馏驱水产生的废水，经冷却塔降温供水喷射系统及洗涤之用。过滤后的铁粉泥可供水泥厂代替铁粉使用。为了防止氧化，在还原中和后及蒸馏时需加入适量抗氧剂。 2.加氢还原法间二硝基苯还原可用合成氨原料气、70%氢氮气进行加氢，采用二元或四元阮尼镍为催化剂（用量20%），以乙醇为溶剂，于110-120℃，氢压3.43-4.41MPa，循环空塔速度每秒0.044平方立米条件下，进行塔式流化床加氢；再经减压蒸馏，即得合格产品，收率90%-95%。物料消耗定额：硝基苯1400kg/t、硝酸787kg/t、硫酸（98%）780kg/t、铁粉3083kg/t。 3. 还原法　由间二硝基苯用铁粉还原或加氢还原制得间苯二胺。
4. 电解法　电解装置由铜板（阴极）、石墨电极（阳极）、H型隔膜式电解槽、稳流电源组成。分别取95%乙醇和15%盐酸各50mL倒入H型电解槽的一边，作为阴极液；再取10%盐酸150mL倒入H型电解槽的另一边作为阳极液。然后把装有电解液的电解槽放入40℃的恒温水浴锅中，并向阴极液中加入间二硝基苯0.25g。接着将打磨过的铜板（S＝20.2cm ²）插入阴极液中，石墨电极插入阳极液中，同时在阴极液中装好电动搅拌器，接好线路，打开电源开关和电动搅拌器开关，调节电流到0.8A，并开始记时36min后关掉电源和电动搅拌器，取出阴极液，分析测定间苯二胺含量。

间苯二胺海关

[ 海关编码 ]: 2921519090

[ 中文概述 ]:
2921519090. 间-、对-苯二胺、二氨基甲苯等〔包括衍生物及它们的盐〕. 增值税率:17.0%. 退税率:17.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2921519090. o-, m-, p-phenylenediamine, diaminotoluenes, and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:17.0%. . MFN tariff:6.5%. General tariff:30.0%

间苯二胺文献

Preparation of three-bore hollow fiber charged nanofiltration membrane for separation of organics and salts.

Water Sci. Technol. 65(1) , 171-6, (2012)

Three-bore hollow fiber charged nanofiltration (NF) membrane was prepared by interfacial polymerization (IP). The results showed that the flux and rejection of NF membrane prepared in this study incre...

A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.

Neuropharmacology 82 , 41-8, (2014)

Kynurenic acid (KYNA) is a tryptophan metabolite that acts in the brain as an endogenous antagonist at multiple receptors, including glutamate and 7 nicotinic acetylcholine receptors. Increased levels...

Hydroxyl functionalized polytriazole-co-polyoxadiazole as substrates for forward osmosis membranes.

ACS Appl. Mater. Interfaces 7(7) , 3960-73, (2015)

Hydroxyl functionalized polytriazole-co-polyoxadiazole (PTA-POD) copolymers have been synthesized and cast as promising highly thermally stable, chemically resistant, and antiorganic/biological foulin...

更多文献